Latest Pulmonology Stories
For U.S. Media Only RIDGEFIELD, Conn., Aug. 19, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S.
Committee Voted Based on Clinical Data from Eight Efficacy Trials RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
For U.S. Media Only RIDGEFIELD, Conn., Aug. 1, 2014 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S.
Scientists from The University of Manchester have discovered why medication to treat asthma and pneumonia can become ineffective.
ANDOVER, Mass., July 24, 2014 /PRNewswire/ -- ndd Medical Technologies, a leader in innovative mobile pulmonary function testing
Patients, caregivers and health care professionals share stories; offer awareness, hope and inspiration CHICAGO, July 23, 2014 /PRNewswire-USNewswire/ -- Twenty of the Pulmonary Fibrosis
Nintedanib and Pirfenidone Received Breakthrough Therapy Designation by the U.S.
Patients with serious heart and lung conditions don't have the normal range of facial expressions, particularly the ability to register surprise in response to emotional cues.
MILAN, July 7, 2014 /PRNewswire/ -- WAIDID, the new International Scientific Society presided over by Prof.
In a new study of the causes underlying respiratory symptoms in military personnel returning from duty in Iraq and Afghanistan, a large percentage of veterans had non-specific symptoms that did not lead to a specific clinical diagnosis.
Human parainfluenza viruses, belonging to the paramyxovirus family, are a group of four distinct serotypes of enveloped single-stranded RNA viruses. They are the second most common cause of lower respiratory tract infection in younger children. Many times the host has repeat infections throughout life with symptoms that may include upper respiratory tract illness or more commonly, a cold and sore throat. It can also cause severe pneumonia in immunosuppressed people. There is currently no...
- A poem in which the author retracts something said in an earlier poem.